Co-Diagnostics, Inc. CODX
$1.14
$0.032.70%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 166.10K | 146.00K | 59.60K | 145.40K | 162.90K |
| Total Other Revenue | -- | -- | 204.30K | -- | -- |
| Total Revenue | 166.10K | 146.00K | 263.90K | 145.40K | 162.90K |
| Cost of Revenue | 45.30K | 193.80K | 142.40K | 26.30K | 32.10K |
| Gross Profit | 120.80K | -47.80K | 121.50K | 119.10K | 130.80K |
| SG&A Expenses | 1.97M | 2.97M | 2.41M | 2.38M | 3.21M |
| Depreciation & Amortization | 201.80K | 255.40K | 267.60K | 267.40K | 291.40K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.37M | 9.35M | 7.92M | 7.16M | 8.22M |
| Operating Income | -6.20M | -9.21M | -7.66M | -7.01M | -8.06M |
| Income Before Tax | -6.26M | -9.14M | -26.22M | -7.05M | -7.72M |
| Income Tax Expenses | 19.20K | 500.00 | -473.70K | -1.17M | 12.30K |
| Earnings from Continuing Operations | -6.28M | -9.14M | -25.75M | -5.89M | -7.73M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -6.28M | -9.14M | -25.75M | -5.89M | -7.73M |
| EBIT | -6.20M | -9.21M | -7.66M | -7.01M | -8.06M |
| EBITDA | -6.00M | -8.95M | -7.39M | -6.75M | -7.77M |
| EPS Basic | -1.46 | -4.06 | -13.67 | -4.66 | -7.00 |
| Normalized Basic EPS | -0.90 | -2.56 | -2.45 | -3.49 | -4.56 |
| EPS Diluted | -1.46 | -4.06 | -13.67 | -4.80 | -7.00 |
| Normalized Diluted EPS | -0.90 | -2.56 | -2.45 | -3.49 | -4.56 |
| Average Basic Shares Outstanding | 4.31M | 2.25M | 1.88M | 1.26M | 1.10M |
| Average Diluted Shares Outstanding | 4.31M | 2.25M | 1.88M | 1.26M | 1.10M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |